<SEC-DOCUMENT>0000950170-24-034171-index.html : 20240320
<SEC-HEADER>0000950170-24-034171.hdr.sgml : 20240320
<ACCEPTANCE-DATETIME>20240320161221
ACCESSION NUMBER:		0000950170-24-034171
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20240320
DATE AS OF CHANGE:		20240320
EFFECTIVENESS DATE:		20240320

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Trevi Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001563880
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				450834299
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-278101
		FILM NUMBER:		24767913

	BUSINESS ADDRESS:	
		STREET 1:		195 CHURCH STREET
		STREET 2:		14TH FLOOR
		CITY:			NEW HAVEN
		STATE:			CT
		ZIP:			06510
		BUSINESS PHONE:		203-304-2499

	MAIL ADDRESS:	
		STREET 1:		195 CHURCH STREET
		STREET 2:		14TH FLOOR
		CITY:			NEW HAVEN
		STATE:			CT
		ZIP:			06510
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>2024_s-8_-_annual_share_.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: 2024_s-8_-_annual_share_.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>trvi-ex5_1.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: trvi-ex5_1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>trvi-ex23_2.htm
<DESCRIPTION>EX-23.2
<TEXT>
Document 3 - file: trvi-ex23_2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>trvi-exfiling_fees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
Document 4 - file: trvi-exfiling_fees.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>img109914091_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: img109914091_0.jpg

</DOCUMENT>
</SEC-DOCUMENT>